Your session is about to expire
← Back to Search
Monoclonal Antibodies
Erenumab-Aooe 140 MG/ML [Aimovig] for Migraine
Phase 4
Waitlist Available
Led By Merle Diamond, MD
Research Sponsored by Merle Diamond
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and treatment months 1, 2, and 3
Awards & highlights
Study Summary
This study is evaluating whether a drug may help reduce the impact of migraines.
Eligible Conditions
- Migraine
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and treatment months 1, 2, and 3
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and treatment months 1, 2, and 3
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Migraine Functional Impact Questionnaire (MFIQ) - "Overall Impact on Usual Activities" Scores at Baseline and at End of Treatment (Treatment Month 3).
Secondary outcome measures
Brief Measure of Worry Severity (BMWS) Scores at Baseline and at Treatment Months 1, 2, and 3
General Self-Efficacy Severity Scale (GSESS) Scores at Baseline and at Treatment Months 1, 2, and 3.
Migraine Functional Impact Questionnaire (MFIQ) - "Impact on Emotional Function" Scores at Baseline and at Treatment Months 1, 2, and 3.
+15 moreSide effects data
From 2022 Phase 4 trial • 55 Patients • NCT044653575%
Constipation
100%
80%
60%
40%
20%
0%
Study treatment Arm
Erenumab-Aooe 140 MG/ML [Aimovig]
Trial Design
1Treatment groups
Experimental Treatment
Group I: Erenumab-Aooe 140 MG/ML [Aimovig]Experimental Treatment1 Intervention
Participants received 140 mg/mL administered subcutaneously once every 4 weeks in the abdomen, thigh, or upper arm for three months (12 weeks).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Erenumab
FDA approved
Find a Location
Who is running the clinical trial?
Merle DiamondLead Sponsor
Clinvest Research, LLCIndustry Sponsor
2 Previous Clinical Trials
204 Total Patients Enrolled
Smith, Timothy R., M.D.INDIV
1 Previous Clinical Trials
30 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger